Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| No statute on record | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AULAKH, CHARANJIT | 1 | 80.9% | -15.6% |
| NESTOR, DONNA MICHELLE | 1 | 57.5% | +43.9% |
| NOLAN, JASON MICHAEL | 1 | 65.7% | -28.3% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.3% | +48.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907722 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | TOWNSLEY, SARA ELIZABETH | 77d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256153 | PHARMACEUTICAL COMPOSITION | NESTOR, DONNA MICHELLE | 2d overdue |
| 17907722 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | TOWNSLEY, SARA ELIZABETH | 77d |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1627 | 1 |
| 1623 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554291 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | AULAKH, CHARANJIT | 1621 | Other | Non-Final OA | 44d overdue | Pending | Oct 06, 2023 |
| 18256153 | PHARMACEUTICAL COMPOSITION | NESTOR, DONNA MICHELLE | 1627 | Other | Final Rejection | 2d overdue | Pending | Jun 06, 2023 |
| 17997422 | CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTIC DRUG | NOLAN, JASON MICHAEL | 1623 | §103 | Final Rejection | 42d overdue | Pending | Oct 28, 2022 |
| 17907722 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | TOWNSLEY, SARA ELIZABETH | 1629 | §103 | Non-Final OA | 77d | Pending | Sep 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial